8693 related articles for article (PubMed ID: 1694058)
1. Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds.
Schlingemann RO; Rietveld FJ; de Waal RM; Ferrone S; Ruiter DJ
Am J Pathol; 1990 Jun; 136(6):1393-405. PubMed ID: 1694058
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis in wound healing and tumor metastasis.
Ruiter DJ; Schlingemann RO; Westphal JR; Denijn M; Rietveld FJ; De Waal RM
Behring Inst Mitt; 1993 Aug; (92):258-72. PubMed ID: 7504453
[TBL] [Abstract][Full Text] [Related]
3. Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature.
Maciag PC; Seavey MM; Pan ZK; Ferrone S; Paterson Y
Cancer Res; 2008 Oct; 68(19):8066-75. PubMed ID: 18829565
[TBL] [Abstract][Full Text] [Related]
4. Idiotypic cascade in the human high molecular weight melanoma-associated antigen system: fine specificity and idiotypic profile of anti-anti-idiotypic monoclonal antibodies.
Yang H; Chen ZJ; Kageshita T; Yamada M; Ferrone S
Eur J Immunol; 1993 Jul; 23(7):1671-7. PubMed ID: 7686858
[TBL] [Abstract][Full Text] [Related]
5. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
6. Human high molecular weight-melanoma associated antigen mimicry by an anti-idiotypic antibody: characterization of the immunogenicity and the immune response to the mouse monoclonal antibody IMel-1.
Chattopadhyay P; Kaveri SV; Byars N; Starkey J; Ferrone S; Raychaudhuri S
Cancer Res; 1991 Nov; 51(22):6045-51. PubMed ID: 1933867
[TBL] [Abstract][Full Text] [Related]
7. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
[TBL] [Abstract][Full Text] [Related]
8. Human high molecular weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody MK2-23. Characterization of the immunogenicity in syngeneic hosts.
Chen ZJ; Yang H; Ferrone S
J Immunol; 1991 Aug; 147(3):1082-90. PubMed ID: 1861071
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants.
Giacomini P; Natali P; Ferrone S
J Immunol; 1985 Jul; 135(1):696-702. PubMed ID: 2582052
[TBL] [Abstract][Full Text] [Related]
10. Human high-molecular-weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody TK7-371.
Chen ZJ; Yang H; Kageshita T; Ferrone S
Cancer Res; 1991 Sep; 51(18):4790-7. PubMed ID: 1716513
[TBL] [Abstract][Full Text] [Related]
11. Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.
Liao SK; Smith JW; Kwong PC; Natali PG; Kusama M; Hamby CV; Ferrone S
Cancer Res; 1987 Sep; 47(18):4835-41. PubMed ID: 3476198
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue.
Schlingemann RO; Rietveld FJ; Kwaspen F; van de Kerkhof PC; de Waal RM; Ruiter DJ
Am J Pathol; 1991 Jun; 138(6):1335-47. PubMed ID: 1711288
[TBL] [Abstract][Full Text] [Related]
13. Modulation by adjuvants and carriers of the immunogenicity in xenogeneic hosts of mouse anti-idiotypic monoclonal antibody MK2-23, an internal image of human high molecular weight-melanoma associated antigen.
Chen ZJ; Yang H; Liu CC; Hirai S; Ferrone S
Cancer Res; 1993 Jan; 53(1):112-9. PubMed ID: 8416734
[TBL] [Abstract][Full Text] [Related]
14. Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.
Mittelman A; Chen ZJ; Yang H; Wong GY; Ferrone S
Proc Natl Acad Sci U S A; 1992 Jan; 89(2):466-70. PubMed ID: 1731316
[TBL] [Abstract][Full Text] [Related]
15. Equilibrium binding characteristics of monoclonal antibodies recognizing melanoma cell surface antigens.
Shockley TR; Mandeville JT; Tompkins RG; Yarmush ML
Hybridoma; 1990 Dec; 9(6):527-44. PubMed ID: 2076895
[TBL] [Abstract][Full Text] [Related]
16. Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
Murray JL; Gillogly M; Kawano K; Efferson CL; Lee JE; Ross M; Wang X; Ferrone S; Ioannides CG
Cancer Res; 2004 Aug; 64(15):5481-8. PubMed ID: 15289358
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of anti HMW.MAA antibodies in sera of melanoma patients using antiidiotypic monoclonal antibodies].
Nakamura T; Kageshita T; Arao T; Yamazaki N; Ishihara K
Nihon Hifuka Gakkai Zasshi; 1990 Oct; 100(11):1121-6. PubMed ID: 2273574
[TBL] [Abstract][Full Text] [Related]
19. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
[TBL] [Abstract][Full Text] [Related]
20. Melanoma targeting with a cocktail of monoclonal antibodies to distinct determinants of the human HMW-MAA.
Matzku S; Kirchgessner H; Schmid U; Temponi M; Ferrone S
J Nucl Med; 1989 Mar; 30(3):390-7. PubMed ID: 2472474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
